Insider holders · CIK 0001643848
Patheon N.V. · PTHN
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Patheon Holdco Cooperatief U.A.10% Owner | — | 19,985,589 | 19,985,589 | Jul 20, 2016 · 8:37 pm EDT | Form 3 |
| JLL/Delta Patheon Holdings, L.P.10% Owner | — | 19,985,589 | 19,985,589 | Jul 20, 2016 · 8:37 pm EDT | Form 3 |
| JLL/Delta Patheon GP, Ltd.10% Owner | — | 19,985,589 | 19,985,589 | Jul 20, 2016 · 8:37 pm EDT | Form 3 |
| JLL Partners Fund V (New Patheon), L.P.10% Owner | — | 19,985,589 | 19,985,589 | Jul 20, 2016 · 8:37 pm EDT | Form 3 |
| Michael LyttonEVP, Corp Development & Strtgy | 227,201 | 386,292 | 613,493 | Jul 22, 2016 · 5:22 pm EDT | Form 4 |
| Raul Cardona TorresSVP, Quality | 0 | — | 0 | Aug 31, 2017 · 6:28 pm EDT | Form 4 |
| Philip EykermanDirector | 0 | — | 0 | Aug 30, 2017 · 7:02 pm EDT | Form 4 |
| Stephan B. TandaDirector | 0 | — | 0 | Aug 30, 2017 · 7:04 pm EDT | Form 4 |
| Francisco R. NegronPresident, Drug Product Svcs | 0 | 0 | 0 | Aug 31, 2017 · 6:26 pm EDT | Form 4 |
| Lukas UtigerPresident, Drug Substance Svcs | 0 | 0 | 0 | Aug 31, 2017 · 6:28 pm EDT | Form 4 |
| Eric SherbetGeneral Counsel and Secretary | 0 | 0 | 0 | Aug 31, 2017 · 6:27 pm EDT | Form 4 |
| JLL Patheon Co-Investment Fund, L.P.10% Owner | — | 0 | 0 | Aug 30, 2017 · 7:03 pm EDT | Form 4 |
| JLL Partners Fund VI (Patheon), L.P.10% Owner | — | 0 | 0 | Aug 30, 2017 · 7:03 pm EDT | Form 4 |
| JLL Associates G.P. V (Patheon), Ltd.10% Owner | — | 0 | 0 | Aug 30, 2017 · 7:03 pm EDT | Form 4 |
| Gary P. PisanoDirector | 0 | — | 0 | Aug 30, 2017 · 7:04 pm EDT | Form 4 |
| Charles I CogutDirector | 0 | — | 0 | Aug 30, 2017 · 7:01 pm EDT | Form 4 |
| Harry R Gill IIISVP, Quality/Continuous Imprvt | 0 | 0 | 0 | Aug 31, 2017 · 6:25 pm EDT | Form 4 |
| Rebecca Holland NewEVP, Enterprise Operations | 0 | 0 | 0 | Aug 31, 2017 · 6:27 pm EDT | Form 4 |
| Michel LagardePresident | 0 | — | 0 | Aug 31, 2017 · 6:30 pm EDT | Form 4 |
| JLL Associates V (Patheon), L.P.10% Owner | — | 0 | 0 | Aug 30, 2017 · 7:03 pm EDT | Form 4 |
| Dean Frederick WilsonChief Accounting Officer | 0 | — | 0 | Aug 31, 2017 · 6:28 pm EDT | Form 4 |
| Michael J. LehmannEVP, Global Sales and Mktng | 0 | 0 | 0 | Aug 31, 2017 · 6:26 pm EDT | Form 4 |
| Stuart GrantEVP and CFO | 0 | 0 | 0 | Aug 31, 2017 · 6:25 pm EDT | Form 4 |
| William B HayesDirector | 0 | — | 0 | Aug 30, 2017 · 7:03 pm EDT | Form 4 |
| Jeffrey P McMullenDirector | 0 | — | 0 | Aug 30, 2017 · 7:04 pm EDT | Form 4 |
| Pamela DaleyDirector | 0 | — | 0 | Aug 30, 2017 · 7:02 pm EDT | Form 4 |
| Craig Eric SchneierEVP and Chief Talent Officer | 0 | — | 0 | Aug 31, 2017 · 6:27 pm EDT | Form 4 |
| James C MullenChief Executive Officer | 0 | 0 | 0 | Aug 31, 2017 · 6:26 pm EDT | Form 4 |
| Hans Peter HaslerDirector | 0 | — | 0 | Aug 30, 2017 · 7:02 pm EDT | Form 4 |
| Gilles CottierPresident, Pharma Dev Svcs | 0 | — | 0 | Aug 31, 2017 · 6:24 pm EDT | Form 4 |
| Koninklijke DSM N.V.10% Owner | 0 | — | 0 | Aug 30, 2017 · 8:32 am EDT | Form 4 |
| Paul S LevyDirector | — | 0 | 0 | Aug 30, 2017 · 7:03 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.